Inhibiting GLS in IDH1-mut glioma cells, in which 2-HG already suppresses BCAT, significantly impairs their fitness by lowering glutamate, glutathione, and resistance to oxidative stress in vitro and to radiation in vitro and in vivo [12]. This evidence concerns the gene IDH1 and central nervous system cancer.